Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer
Alcides Chaux(Johns Hopkins University), George J. Netto(University of Pennsylvania)
Cited by 132
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
|PubMed|2022|172